These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1164 related items for PubMed ID: 17182990

  • 1. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.
    N Engl J Med; 2006 Dec 21; 355(25):2652-63. PubMed ID: 17182990
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
    Ercoli LM, Small GW, Siddarth P, Kepe V, Huang SC, Miller KJ, Lavretsky H, Bookheimer SY, Barrio JR, Silverman DH.
    Int J Geriatr Psychiatry; 2012 Oct 21; 27(10):1017-27. PubMed ID: 22383132
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 2-(1-{6-[(2-[fluorine-18]fluoroethyl)(methyl) amino]-2-naphthyl} ethylidene)malononitrile (FDDNP) positron emission tomography patterns in nondemented populations.
    Shin J, Lee SY.
    Am J Geriatr Psychiatry; 2010 Feb 21; 18(2):187; author reply 188. PubMed ID: 20104075
    [No Abstract] [Full Text] [Related]

  • 11. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.
    Braskie MN, Klunder AD, Hayashi KM, Protas H, Kepe V, Miller KJ, Huang SC, Barrio JR, Ercoli LM, Siddarth P, Satyamurthy N, Liu J, Toga AW, Bookheimer SY, Small GW, Thompson PM.
    Neurobiol Aging; 2010 Oct 21; 31(10):1669-78. PubMed ID: 19004525
    [Abstract] [Full Text] [Related]

  • 12. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.
    Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR.
    Am J Geriatr Psychiatry; 2002 Oct 21; 10(1):24-35. PubMed ID: 11790632
    [Abstract] [Full Text] [Related]

  • 13. Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints.
    Merrill DA, Siddarth P, Raji CA, Emerson ND, Rueda F, Ercoli LM, Miller KJ, Lavretsky H, Harris LM, Burggren AC, Bookheimer SY, Barrio JR, Small GW.
    Am J Geriatr Psychiatry; 2016 Sep 21; 24(9):729-37. PubMed ID: 27421618
    [Abstract] [Full Text] [Related]

  • 14. The merits of FDDNP-PET imaging in Alzheimer's disease.
    Shin J, Kepe V, Barrio JR, Small GW.
    J Alzheimers Dis; 2011 Sep 21; 26 Suppl 3():135-45. PubMed ID: 21971458
    [Abstract] [Full Text] [Related]

  • 15. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters CL, Yanai K, Rowe CC, Villemagne VL.
    Brain; 2014 Jun 21; 137(Pt 6):1762-71. PubMed ID: 24681664
    [Abstract] [Full Text] [Related]

  • 16. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST.
    Brain; 2008 Jun 21; 131(Pt 6):1630-45. PubMed ID: 18339640
    [Abstract] [Full Text] [Related]

  • 17. Seeing is believing: neuroimaging adds to our understanding of cerebral pathology.
    Small GW, Kepe V, Barrio JR.
    Curr Opin Psychiatry; 2006 Nov 21; 19(6):564-9. PubMed ID: 17012932
    [Abstract] [Full Text] [Related]

  • 18. Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
    Furukawa K, Okamura N, Tashiro M, Waragai M, Furumoto S, Iwata R, Yanai K, Kudo Y, Arai H.
    J Neurol; 2010 May 21; 257(5):721-7. PubMed ID: 19946781
    [Abstract] [Full Text] [Related]

  • 19. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, Hinz R, Biju M, Kuruvilla T, Brooks DJ, Edison P.
    Brain; 2018 Sep 01; 141(9):2740-2754. PubMed ID: 30052812
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 59.